Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Certain inhibitors applied to the skin can promote hair growth by maintaining a key hair growth signal.

Certain genes can predict how well breast cancer patients respond to chemotherapy.

Trypsin slows hair growth and affects color by causing cell death in hair follicles.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Adalimumab can cause hair loss and scalp issues in some psoriasis patients.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

PRP is more effective than triamcinolone for treating alopecia areata.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Skin tumor cells in patients with tuberous sclerosis have higher levels of a protein called cathepsin B.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Enzyme replacement therapy improved multiple symptoms of homocystinuria in mice.

Ustekinumab helped three kids with alopecia areata regrow hair.

Pimecrolimus boosts melanin production and movement of skin pigment cells.

PEVIII is a promising treatment for Pseudomonas aeruginosa keratitis.

Immunoadsorption successfully treated a man's resistant polymyositis.

HA-P5 effectively treats acne without causing side effects seen in other treatments.

Platelet-rich plasma therapy can increase FDG uptake in the scalp.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Activated protein C helps protect mice from long-term radiation damage.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

The document corrects a mistake by stating that pimecrolimus, not tacrolimus, is the drug that concentrates in the skin.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Tofacitinib is an effective and safe treatment for alopecia areata.